EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Melatonin MT1 receptors as a target for the psychopharmacology of bipolar disorder: A translational study

Margherita Tassan Mazzocco, Claudia Pisanu, Luigi Russo, Clementina Acconcia, Marco Cambiaghi, Sofia De Girolamo, Alessio Squassina, Laura Cherchi, Elena Monzani, Francesca Scebba, Debora Angeloni, Danilo De Gregorio und 19 weitere

Pharmacological Research · 2023

DOI: 10.1016/j.phrs.2023.106993 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacological Research, 2023. Verfasst von Margherita Tassan Mazzocco und 30 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS San Raffaele Scientific Institute, Milan, Italy; School of Medicine, Vita Salute San Raffaele University, Milan, Italy. Hauptthemen laut MEDLINE: Bipolar Disorder, Melatonin, Psychopharmacology. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brain and Behavior Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The treatment of bipolar disorder (BD) still remains a challenge. Melatonin (MLT), acting through its two receptors MT1 and MT2, plays a key role in regulating circadian rhythms which are dysfunctional in BD. Using a translational approach, we examined the implication and potential of MT1 receptors in the pathophysiology and psychopharmacology of BD. We employed a murine model of the manic phase of BD (Clock mutant (ClockΔ19) mice) to study the activation of MT1 receptors by UCM871, a selective partial agonist, in behavioral pharmacology tests and in-vivo electrophysiology. We then performed a high-resolution Nuclear Magnetic Resonance study on isolated membranes to characterize the molecular mechanism of interaction of UCM871. Finally, in a cohort of BD patients, we investigated the link between clinical measures of BD and genetic variants located in the MT1 receptor and CLOCK genes. We demonstrated that: 1) UCM871 can revert behavioral and electrophysiological abnormalities of ClockΔ19 mice; 2) UCM871 promotes the activation state of MT1 receptors; 3) there is a significant association between the number of severe manic episodes and MLT levels, depending on the genetic configuration of the MT1 rs2165666 variant. Overall, this work lends support to the potentiality of MT1 receptors as target for the treatment of BD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderMelatoninPsychopharmacologyHumansMiceAnimalsReceptor, Melatonin, MT1Receptor, Melatonin, MT2

Stichwörter der Autor:innen

Bipolar disorderClock geneMT(1) receptorMelatoninNuclear Magnetic ResonanceUCM871

Substanzen

MelatoninReceptor, Melatonin, MT1Receptor, Melatonin, MT2

Autor:innen und Institutionen

  • IRCCS San Raffaele Scientific Institute, Milan, Italy; School of Medicine, Vita Salute San Raffaele University, Milan, Italy.
  • Department of Biomedical Science, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Monserrato, Cagliari, Italy.
  • Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania "L. Vanvitelli", Caserta, Italy.
  • Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Health Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Via G. Moruzzi, 56124 Pisa, Italy.

Förderung

  • Brain and Behavior Research Foundation

Zitieren

APA

Tassan Mazzocco, M., Pisanu, C., Russo, L., Acconcia, C., Cambiaghi, M., De Girolamo, S., Squassina, A., Cherchi, L., Monzani, E., Scebba, F., Angeloni, D., De Gregorio, D., Nasini, S., Dall'Acqua, S., Sut, S., Suprani, F., Garzilli, M., Guiso, B., Pulcinelli, V., …, & Comai, S. (2023). Melatonin MT1 receptors as a target for the psychopharmacology of bipolar disorder: A translational study. Pharmacological Research. https://doi.org/10.1016/j.phrs.2023.106993

Vancouver

Tassan Mazzocco M, Pisanu C, Russo L, Acconcia C, Cambiaghi M, De Girolamo S, et al. Melatonin MT1 receptors as a target for the psychopharmacology of bipolar disorder: A translational study. Pharmacological Research. 2023. doi:10.1016/j.phrs.2023.106993

BibTeX
@article{TassanMazzocco2023,
  author = {Tassan Mazzocco, Margherita and Pisanu, Claudia and Russo, Luigi and Acconcia, Clementina and Cambiaghi, Marco and De Girolamo, Sofia and Squassina, Alessio and Cherchi, Laura and Monzani, Elena and Scebba, Francesca and Angeloni, Debora and De Gregorio, Danilo and Nasini, Sofia and Dall'Acqua, Stefano and Sut, Stefania and Suprani, Federico and Garzilli, Mario and Guiso, Beatrice and Pulcinelli, Vittoria and Iaselli, Maria Novella and Pinna, Ilaria and Somaini, Giulia and Arru, Laura and Corrias, Carolina and Paribello, Pasquale and Pinna, Federica and Gobbi, Gabriella and Valtorta, Flavia and Carpiniello, Bernardo and Manchia, Mirko and Comai, Stefano},
  title = {Melatonin MT1 receptors as a target for the psychopharmacology of bipolar disorder: A translational study},
  journal = {Pharmacological Research},
  year = {2023},
  doi = {10.1016/j.phrs.2023.106993}
}
Kostenlos starten →